Synthesis and receptor binding of 5-amino[3H]2methyl-3-isothiazolol ([3H]thiomuscimol), a specific GABAa agonist photoaffinity label
✍ Scribed by B. Frølund; B. Ebert; L. W. Lawrence; S. D. Hurt; P. Krogsgaard-Larsen
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 524 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The synthesis of tritium labelled thiomuscimol(5‐amino[^3^H]~2~methyl‐3‐isothiazolol) (7c), a specific and high‐affinity agonist photoaffinity label for GABA~A~ receptors, is described. The synthesis of 7c is based on a procedure for the preparation of 5‐amino[^2^H]~2~methyl‐3‐isothiazolol (7b). Methyl 3‐ethoxyisothiazole‐5‐carboxylate (3), synthesized from 3‐hydroxyisothiazole‐5‐carboxamide (1) via the corresponding methyl ester (2), was reduced with sodium borotritide to give 3‐ethoxy‐5‐hydroxy[^3^H]~2~methyl‐3‐isothiazole (4c). 3‐Ethoxy‐5‐phthalimido[^3^H]~2~‐methylisothiazole (6c), synthesized from the 5‐chloro[^3^H]~2~methyl analogue (5c) of (4c), was deprotected by treatment with concentrated hydrochloric acid to give 7c with a specific radioactivity of 29 Ci/mmol. In pilot binding assays, 7c was shown to bind to membranes from rat forebrain in a saturable manner and with K~D~ and B~max~ values of 28 ± 6 nM and 50 ± 4 fmol/mg original tissue, respectively.
📜 SIMILAR VOLUMES
We have previously shown that (RS)-2-amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]propionic acid (2-Me-Tet-AMPA) is a selective agonist at (RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors, markedly more potent than AMPA itself, whereas the isomeric com
Specific [ ' H I and [ 3H] labelled methyl-hydroxylated derivatives of 7,12-dimethylbenz[a]anthracene (DMBA), 7-hydroxymethyl-12methylbenz[a]anthracene, 7-methyl-12-hydroxymethylbenz[a]anthracene, and 7,12-dihydroxymethylbenz[a]anthracene, were synthesized with good yield and high specific activity.
3 H]-Labelled 4- [ethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[ 3 H]-butan-1-ol (3b) was prepared as a novel non-peptidic radiolabelled high affinity antagonist of the corticotropin-releasing hormone type 1 receptor (CRHR 1 ) that could be useful as a more